WASHINGTON — Now that the health care overhaul has passed Congress, Democratic lawmakers are hoping to highlight its most immediate benefits. Chief among them: a plan to help millions of elderly and disabled Medicare beneficiaries pay for their medications by gradually eliminating a prescription-drug coverage gap commonly known as the "doughnut hole."
"Who among us will not be more secure knowing that our parents will be protected from the Medicare Part D 'doughnut hole,' which has made lifesaving medications so unaffordable for those that need them most?" Rep. Lucille Roybal-Allard, D-Calif., said after the vote on the legislation in the House of Representatives.
The doughnut hole is a complicated contraption, however, and filling it is far from simple. Here's a close look at how the doughnut hole works and how it would be closed.
Q: What is the doughnut hole?
Sign Up and Save
Get six months of free digital access to The Idaho Statesman
A: In 2003, Congress passed legislation that created the Medicare drug benefit, which went into effect in 2006. Private insurers offer the benefit through free-standing drug plans and Medicare Advantage plans, which also offer medical benefits.
The Part D plans have some leeway in how they design their coverage. Under the typical benefit for this year, however, beneficiaries have to pay deductibles of $310 and monthly premiums that average $38.94. After they meet the deductible, beneficiaries are required to pay 25 percent of their drug costs; their drug plans, which the government subsidizes, pick up the rest.
Once total spending by the patients and their drug plans exceeds $2,830, the beneficiaries hit the coverage gap, in which they must pay the full cost of their medications. After they spend another $3,610, they're eligible for what's called "catastrophic" coverage, under which they pay only 5 percent of their drug costs.
Q: What will the new law do to close the gap?
A: Beginning this year, any Medicare beneficiary who reaches the doughnut hole will receive a $250 check to help pay for his or her drugs.
Then, starting in January, patients in the coverage gap will get 50 percent discounts on brand-name drugs. The drug companies will finance the price reduction as part of a deal with the White House, in which the industry made tens of billions of dollars in price concessions.
The federal government will play a big role, too, in closing the doughnut hole. In 2013, the government will begin providing subsidies for brand-name drugs bought by seniors who hit the coverage gap. The government's share will start off small, at 2.5 percent, but will increase to 25 percent by 2020. At that point, the combined industry discounts and government subsidies will add up to 75 percent of brand-name drug costs.
Generic drugs — which cost far less than brand-name drugs do — will be dealt with separately. Beginning next year, government subsidies will cover 7 percent of generic drug costs once people hit the doughnut hole. Washington will pick up additional portions each year until 2020, when federal dollars will cover 75 percent of generic drug costs.
At that point, the doughnut hole effectively will be closed.
Q: Who will be affected?
A: The agency that runs Medicare reported this month that 29 million seniors and people with disabilities are enrolled in Medicare drug plans, or about two-thirds of the Medicare population. Roughly 3.4 million people entered the doughnut hole in 2007, the most recent year for which estimates are available. An additional number spent enough to enter the doughnut hole but didn't have to pay for their medications out of pocket because they had low incomes and received separate subsidies.
"This is a very vulnerable population," said Hilary Dalin of the National Council on Aging, noting that many people who reach the doughnut hole suffer from multiple chronic conditions and take many medications. Once they enter the coverage gap, "they're really thinking about cost versus care, which is a terrible proposition for anybody," she said.
A study by the Kaiser Family Foundation found that of those who entered the coverage gap, 15 percent stopped taking their medications altogether. Among diabetics, 10 percent stopped taking their medicines, a decision that can have severe consequences. (Kaiser Health News is an editorially independent part of the Kaiser Family Foundation.)
"With the cost of prescription drugs continuing to skyrocket, closing the 'doughnut hole' will help millions of older Americans afford their needed medications and avoid more intensive and costly care later in life," A. Barry Rand, the AARP's top executive, said in a statement.
Q: Why did Congress create the doughnut hole in the first place?
A: The doughnut hole is all about the money. The Republican-controlled Congress in 2003 ponied up $400 billion for the Part D benefit over 10 years, but that wasn't enough to construct a benefit that didn't have a gaping hole.
"There is no policy justification for the doughnut hole," said Gail Wilensky, a former head of the Medicare agency and an adviser to numerous Republican lawmakers. "The politicians wanted to keep the deductible low enough to touch a lot of people."
Indeed, even among opponents of the new health care measure, filling the doughnut hole remains uncontroversial. "Nobody ever liked it," said Robert Moffit, a policy analyst at the conservative Heritage Foundation. "It was literally a product of the congressional imagination created in order to meet budgetary requirements."
Q: How much will it cost to fill the doughnut hole?
A: An estimate by the Congressional Budget Office says that closing the coverage gap will cost the federal government $42.6 billion by 2019.
However, the federal subsidies that will help close the doughnut hole will be phased in slowly. The full subsidies won't be in effect until 2020, after the period captured in the cost estimates, and the cost of filling the hole would increase in the following years.
(Kaiser Health News is an editorially independent news service and is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization that's not affiliated with Kaiser Permanente.)
MORE FROM KAISER HEALTH NEWS
MORE FROM MCCLATCHY